The European Medicines Agency (EMA) is currently looking for a new location in connection with the UK’s withdrawal from the EU. Sweden has now submitted its official offer to host the EMA.
STOCKHOLM, 03-Aug-2017 — /EuropaWire/ — The offer guarantees the smooth relocation of the EMA and its staff to Stockholm, which provides a unique and world-leading life sciences environment and successful cooperation between health care, academia and industry.
“The EMA is strategically important for the EU’s global competitiveness. We are convinced that Sweden’s offer is best able to benefit the EMA and the EU as a whole,” says Prime Minister Stefan Löfven.
“The EMA is an extremely important agency for health and medical care and patient safety in the European Union. Sweden and Stockholm can provide the seamless transition required,” says Minister for Health and Social Affairs Annika Strandhäll.
Strandhäll argues that Sweden more than meets the criteria established by the European Commission and, in addition, has several unique advantages:
– The Swedish Medical Products Agency is already one of the EMA’s most active partners and thereby a valuable asset. The Agency will also increase its staffing to assist the EMA in the event of a move.
– Karolinska Institutet – the EMA is offered a research environment that includes one of the world’s foremost medical universities and the Nobel Assembly as its closest neighbours.
– Synergy effects with the ECDC – Sweden already hosts the European Centre for Disease Prevention and Control (ECDC). This will help strengthen public health protection while improving EU resource efficiency.
Press Secretary to Minister for Social Security Annika Strandhäll
SOURCE: Government Offices of Sweden